NO871783L - Fremgangsmaate for fremstilling av lmv-heparin. - Google Patents

Fremgangsmaate for fremstilling av lmv-heparin.

Info

Publication number
NO871783L
NO871783L NO871783A NO871783A NO871783L NO 871783 L NO871783 L NO 871783L NO 871783 A NO871783 A NO 871783A NO 871783 A NO871783 A NO 871783A NO 871783 L NO871783 L NO 871783L
Authority
NO
Norway
Prior art keywords
lmv
heparin
procedure
manufacturing
manufacturing lmv
Prior art date
Application number
NO871783A
Other languages
English (en)
Other versions
NO167208B (no
NO167208C (no
NO871783D0 (no
Inventor
Joergen Ilum Nielsen
Per Bjoern Oestergaard
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of NO871783D0 publication Critical patent/NO871783D0/no
Publication of NO871783L publication Critical patent/NO871783L/no
Publication of NO167208B publication Critical patent/NO167208B/no
Publication of NO167208C publication Critical patent/NO167208C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
NO871783A 1986-04-30 1987-04-29 Fremgangsmaate for fremstilling av heparin med lav molekylvekt (lmv-heparin). NO167208C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK196986A DK196986D0 (da) 1986-04-30 1986-04-30 Fremstilling af polysaccharider

Publications (4)

Publication Number Publication Date
NO871783D0 NO871783D0 (no) 1987-04-29
NO871783L true NO871783L (no) 1987-11-02
NO167208B NO167208B (no) 1991-07-08
NO167208C NO167208C (no) 1991-10-16

Family

ID=8109197

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871783A NO167208C (no) 1986-04-30 1987-04-29 Fremgangsmaate for fremstilling av heparin med lav molekylvekt (lmv-heparin).

Country Status (7)

Country Link
EP (1) EP0244236A3 (no)
JP (1) JPS62283103A (no)
AU (1) AU588102B2 (no)
CA (1) CA1334081C (no)
DK (1) DK196986D0 (no)
FI (1) FI90090C (no)
NO (1) NO167208C (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
DK196886D0 (da) * 1986-04-30 1986-04-30 Novo Industri As Fremstilling af polysaccharider
IT1213384B (it) * 1986-11-24 1989-12-20 Lab Derivati Organici Mediolan Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.
NL8900119A (nl) * 1989-01-19 1990-08-16 Akzo Nv Werkwijze voor het afsplitsen van (delta)4-onverzadigd uronzuur in glycosaminoglycaan fragmenten.
USRE38743E1 (en) 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
DK0946185T4 (da) * 1996-11-27 2010-08-30 Aventis Pharma Inc Farmaceutisk præparat, som omfatter en forbindelse med anti-Xa-aktivitet og en blodpladeaggregations antagonistforbindelse
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
CA2402160C (en) 2000-03-08 2012-02-14 Massachusetts Institute Of Technology Heparinase iii and uses thereof
ATE426805T1 (de) 2000-09-12 2009-04-15 Massachusetts Inst Technology Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
CA2423469A1 (en) 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
EP2402753A1 (en) 2002-03-11 2012-01-04 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
WO2007140231A2 (en) * 2006-05-25 2007-12-06 Momenta Pharmaceutical, Inc. Low molecular weight heparin composition and uses thereof
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
ES2817779T3 (es) 2010-01-19 2021-04-08 Momenta Pharmaceuticals Inc Evaluación de preparaciones de heparina
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN103214596A (zh) * 2013-05-14 2013-07-24 枣庄赛诺康生化股份有限公司 由肝素钠粗品直接生产低分子量肝素钠的方法
CN103323416A (zh) * 2013-07-04 2013-09-25 苏州良辰生物医药科技有限公司 一种肝素浓度的测定方法
CN108117614B (zh) * 2016-11-29 2020-09-04 北京碧澄生物科技有限公司 低分子量肝素
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
CN114616340A (zh) 2019-07-09 2022-06-10 奥普蒂姆维亚有限公司 合成抗凝血多糖的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
US4396762A (en) * 1981-08-24 1983-08-02 Massachusetts Institute Of Technology Heparinase derived anticoagulants
DK196886D0 (da) * 1986-04-30 1986-04-30 Novo Industri As Fremstilling af polysaccharider

Also Published As

Publication number Publication date
CA1334081C (en) 1995-01-24
JPS62283103A (ja) 1987-12-09
FI90090B (fi) 1993-09-15
FI871910A0 (fi) 1987-04-29
DK196986D0 (da) 1986-04-30
AU588102B2 (en) 1989-09-07
NO167208B (no) 1991-07-08
EP0244236A2 (en) 1987-11-04
EP0244236A3 (en) 1988-09-28
NO167208C (no) 1991-10-16
FI871910A (fi) 1987-10-31
AU7225587A (en) 1987-11-05
FI90090C (fi) 1993-12-27
JPH0542919B2 (no) 1993-06-30
NO871783D0 (no) 1987-04-29

Similar Documents

Publication Publication Date Title
NO871783L (no) Fremgangsmaate for fremstilling av lmv-heparin.
FI873346A0 (fi) Foerfarande foer framstaellning av morfologiskt homogena former av thiazolderivat.
FI870222A0 (fi) Foerfarande foer foerbaettring av haollfastheten hos fanerskivor innehaollande svarvsprickor.
NO882295D0 (no) Fremgangsmaate for fremstilling av paryledimeren.
DE3780489D1 (de) Abscheidungsverfahren.
NO894583D0 (no) Fremgangsmaate for fremstilling av celleplast.
FI871367A0 (fi) Foerfarande foer oevervakning av funktionen hos en foerbraenningsmotor.
DE3778616D1 (de) Heparin-testverfahren.
NO885200L (no) Fremgangsmaate for fremstilling av pro-legemidler.
NO168864C (no) Fremgangsmaate for dekaffeinering av raakaffe.
NO872690L (no) FremgangsmŸte for fremstilling av mercaptoacylprolin.
FI874159A0 (fi) Anordning foer tillverkning av ringformiga polymerartiklar.
NO863520D0 (no) Fremgangsmaate for fremstilling av flerlags kretskort.
NO874261D0 (no) Fremgangsmaate for fremstilling av tepper.
FI871439A0 (fi) Anordning foer toemning av behaollare.
NO892921D0 (no) Fremgangsmaate for fremstilling av celleplast.
SE8602171D0 (sv) Forfarande for framstellning av antrakinoner
SE8703800D0 (sv) Forfarande for framstellning av akvarier, terrarier eller liknande konstruktioner
NO880379L (no) Fremgangsmaate til fremstilling av glass.
ES521910A0 (es) Procedimiento de fabricacion de cestas de cesta-punta.
ATE75503T1 (de) Heparin-testverfahren.
FI864722A (fi) Anordning foer bestaemning av filtreringsfoermaogan hos pappersmassa.
NO842018L (no) Fremgangsmaate for fremstilling av arylestere.
FI860102A0 (fi) Tillsatsaemnesblandningar avsedda i synnerhet foer foerbaettring av kallfiltrerbarhetsegenskaperna hos mellandestillat av raoolja.
NO881843D0 (no) Fremgangsmaate for fremstilling av aec-inhibitorer.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees